$KLDO News Article - Kaleido Biosciences Announces Presentation of Clinical Study and Ex Vivo Data Supporting the Development of Novel Microbiome Metabolic Therapies for Hyperammonemia at The International Liver Congress(TM) 2019 (EASL)
https://marketwirenews.com/news-releases/kale...90462.html